Influence of SGLT2 inhibitors on plasma glycemic fluctuations and oxidative stress in patients with newly diagnosed type 2 diabetes mellitus

被引：0
|
作者：
Zhou, Peihua [1 ]
Ma, Jianhua [1 ]
Li, Fengfei [1 ]
机构：
[1] Nanjing First Hosp, Nanjing, Jiangsu, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2016年 / 32卷 / SUPP 2期
关键词：
SGLT2; inhibitors; dapagliflozin; T2DM; blood glycemic fluctuations; oxidative stress;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
384458
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [21] SGLT2 inhibitors in the treatment of type 2 diabetes
    Hasan, Farhad M.
    Alsahli, Mazen
    Gerich, John E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) : 297 - 322
  • [22] SGLT2 inhibitors in the management of type 2 diabetes
    R. P. Monica Reddy
    Silvio E. Inzucchi
    Endocrine, 2016, 53 : 364 - 372
  • [23] SGLT2 inhibitors in the management of type 2 diabetes
    Reddy, R. P. Monica
    Inzucchi, Silvio E.
    ENDOCRINE, 2016, 53 (02) : 364 - 372
  • [24] Role of SGLT2 inhibitors in type 2 diabetes mellitus in polycystic ovary syndrome
    Salau, F.
    Chatakondi, R. N.
    Pruett, J.
    Cardozo, L. Yanes
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S74 - S75
  • [25] The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments
    Garcia-Ropero, Alvaro
    Badimon, Juan J.
    Santos-Gallego, Carlos G.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (12) : 1287 - 1302
  • [26] POTENTIAL PLACE OF SGLT2 INHIBITORS IN TREATMENT PARADIGMS FOR TYPE 2 DIABETES MELLITUS
    Handelsman, Yehuda
    ENDOCRINE PRACTICE, 2015, 21 (09) : 1054 - 1065
  • [27] Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment
    Rizzo, Maria Rosaria
    Di Meo, Irene
    Polito, Rita
    Auriemma, Maria Chiara
    Gambardella, Antonio
    di Mauro, Gabriella
    Capuano, Annalisa
    Paolisso, Giuseppe
    PHARMACOLOGICAL RESEARCH, 2022, 176
  • [28] Why are SGLT2 inhibitors a good choice in the management of Type 2 Diabetes Mellitus?
    Ghazanfar, Nhila
    WORLD FAMILY MEDICINE, 2021, 19 (07): : 86 - 88
  • [29] A Study to Evaluate the Effect of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors on Oxidative Stress Parameters in Type 2 Diabetes Mellitus Patients
    Sharma, Ankita
    Aruna, D.
    Beatrice, Anne
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [30] The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus
    Hadi Fattah
    Volker Vallon
    Drugs, 2018, 78 : 717 - 726
12345